Figure 8.
Effect of VWF, VWF fragments, and VWF mutants on platelet adhesion to fibrin. (A) Human fibrin surfaces were incubated with SpII (200 μg/mL), SpIII (200 μg/mL), plasma-purified VWF (5 μg/mL), and plasma-purified VWF (5 μg/mL) in the presence of 200 μg/mL VWF fragments SpII or SpIII. (B) Human fibrin surfaces were incubated with WT-rVWF (5 μg/mL), ΔD4B-rVWF (5 μg/mL), and ΔC1C2-rVWF (5 μg/mL) and D1746G-rVWF (5 μg/mL) for 2 hours at ambient temperature. After removing nonbound material, plasma-free blood was perfused at a shear rate of 1500 s–1 over the fibrin surfaces for 3 minutes. Platelet adhesion data are calculated relative to the mean value obtained with fibrin that was incubated with plasma-purified VWF (A) or WT-rVWF (B). Controls are nontreated fibrin layers. Error bars indicate SEM.

Effect of VWF, VWF fragments, and VWF mutants on platelet adhesion to fibrin. (A) Human fibrin surfaces were incubated with SpII (200 μg/mL), SpIII (200 μg/mL), plasma-purified VWF (5 μg/mL), and plasma-purified VWF (5 μg/mL) in the presence of 200 μg/mL VWF fragments SpII or SpIII. (B) Human fibrin surfaces were incubated with WT-rVWF (5 μg/mL), ΔD4B-rVWF (5 μg/mL), and ΔC1C2-rVWF (5 μg/mL) and D1746G-rVWF (5 μg/mL) for 2 hours at ambient temperature. After removing nonbound material, plasma-free blood was perfused at a shear rate of 1500 s–1 over the fibrin surfaces for 3 minutes. Platelet adhesion data are calculated relative to the mean value obtained with fibrin that was incubated with plasma-purified VWF (A) or WT-rVWF (B). Controls are nontreated fibrin layers. Error bars indicate SEM.

Close Modal

or Create an Account

Close Modal
Close Modal